Synopsis
0
JDMF
0
VMF
0
FDF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Thickeners and Stabilizers
Lubricants & Glidants
Coating Systems & Additives
Co-Processed Excipients
Granulation
Disintegrants & Superdisintegrants
Film Formers & Plasticizers
Empty Capsules
Taste Masking
Controlled & Modified Release
Chewable & Orodispersible Aids
Topical
Emulsifying Agents
Coloring Agents
Parenteral
Solubilizers
API Stability Enhancers
Surfactant & Foaming Agents
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Terazosin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terazosin Hydrochloride, including repackagers and relabelers. The FDA regulates Terazosin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terazosin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Terazosin Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Terazosin Hydrochloride supplier is an individual or a company that provides Terazosin Hydrochloride active pharmaceutical ingredient (API) or Terazosin Hydrochloride finished formulations upon request. The Terazosin Hydrochloride suppliers may include Terazosin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Terazosin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Terazosin Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Terazosin Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Terazosin Hydrochloride DMFs exist exist since differing nations have different regulations, such as Terazosin Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Terazosin Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Terazosin Hydrochloride USDMF includes data on Terazosin Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Terazosin Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Terazosin Hydrochloride suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Terazosin Hydrochloride Drug Master File in Korea (Terazosin Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Terazosin Hydrochloride. The MFDS reviews the Terazosin Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Terazosin Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Terazosin Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Terazosin Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Terazosin Hydrochloride suppliers with KDMF on PharmaCompass.
A Terazosin Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Terazosin Hydrochloride Certificate of Suitability (COS). The purpose of a Terazosin Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Terazosin Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Terazosin Hydrochloride to their clients by showing that a Terazosin Hydrochloride CEP has been issued for it. The manufacturer submits a Terazosin Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Terazosin Hydrochloride CEP holder for the record. Additionally, the data presented in the Terazosin Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Terazosin Hydrochloride DMF.
A Terazosin Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Terazosin Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Terazosin Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Terazosin Hydrochloride written confirmation (Terazosin Hydrochloride WC) is an official document issued by a regulatory agency to a Terazosin Hydrochloride manufacturer, verifying that the manufacturing facility of a Terazosin Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Terazosin Hydrochloride APIs or Terazosin Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Terazosin Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Terazosin Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Terazosin Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Terazosin Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Terazosin Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Terazosin Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Terazosin Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Terazosin Hydrochloride suppliers with NDC on PharmaCompass.
Terazosin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Terazosin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Terazosin Hydrochloride GMP manufacturer or Terazosin Hydrochloride GMP API supplier for your needs.
A Terazosin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Terazosin Hydrochloride's compliance with Terazosin Hydrochloride specifications and serves as a tool for batch-level quality control.
Terazosin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Terazosin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Terazosin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Terazosin Hydrochloride EP), Terazosin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Terazosin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
